This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography
The following Wikipedia contributor has declared a personal or professional connection to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view.
RoderickMacKinnon (talk·contribs) This user has contributed to the article. This user has declared a connection. (Confirmed via OTRS)
I'm going to divide this article into sections, and reword a few things. I might also look for more references and try to improve the footnoting in this article. If there are any objections, please feel free to discuss/change my edits. PDCook (talk) 15:25, 11 February 2010 (UTC)[reply]
Business activities
Actually, I think that might be a reasonable removal for the BLP page. This is not something the subject is famous for. But on the other hand, this is not really something contentious and could stay, unless someone can explain why this is really problematic. My very best wishes (talk) 15:37, 22 August 2018 (UTC)[reply]
Nope, this is legit content with plenty of independent sourcing. Lots of academic scientists get involved with companies - it is entirely normal and DUE. I thought perhaps there might have been a falling out, but he is still on their SAB, per that page on the company website. This is not "private" information by any means. I don't understand why he doesn't like it, but subject's feelings are not the determining factor when we consider encyclopedia content. Jytdog (talk) 15:45, 22 August 2018 (UTC)[reply]
Yes, this is certainly not a private info, and I agree, this may be reasonably viewed as "due" content. Of course someone can argue how much of this should be included, or how exactly this should be phrased. My very best wishes (talk) 15:52, 22 August 2018 (UTC)[reply]
OK, I think I understand what might be the issue now; see these diffs for the recent developments. I didn't add this to the page, but the 10-Q cited there also discloses that there is now a shareholder lawsuit against the company and some of its executives, that was filed in June 2018 just after the company announced it was halting clinical development. Stanford has a website where it tracks securities litigation, and the case is here. MacKinnon is not named in the filing that is posted at the Stanford site. Jytdog (talk) 18:53, 22 August 2018 (UTC)[reply]
